Development and validation of a prognostic model in patients with metastatic renal cell carcinoma tr...
Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration
About this item
Full title
Author / Creator
Bamias, A , Tzannis, K , Beuselinck, B , Oudard, S , Escudier, B , Diosynopoulos, D , Papazisis, K , Lang, H , Wolter, P , de Guillebon, E , Stravodimos, K , Chrisofos, M , Fountzilas, G , Elaidi, R-T , Dimopoulos, M A and Bamia, C
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Background:
Accurate prediction of outcome for metastatic renal cell carcinoma (mRCC) patients receiving targeted therapy is essential. Most of the available models have been developed in patients treated with cytokines, while most of them are fairly complex, including at least five factors. We developed and externally validated a simple model f...
Alternative Titles
Full title
Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3721408
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3721408
Other Identifiers
ISSN
0007-0920
E-ISSN
1532-1827
DOI
10.1038/bjc.2013.341
